- Home
- KNSA vs ENLT Comparison
KNSA vs ENLT Comparison
Compare KNSA & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- ENLT
- Stock Information
- Founded
- KNSA 2015
- ENLT 2008
- Country
- KNSA United Kingdom
- ENLT Israel
- Employees
- KNSA N/A
- ENLT N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- ENLT
- Sector
- KNSA Health Care
- ENLT
- Exchange
- KNSA Nasdaq
- ENLT Nasdaq
- Market Cap
- KNSA 2.6B
- ENLT 2.9B
- IPO Year
- KNSA 2018
- ENLT 2023
- Fundamental
- Price
- KNSA $38.01
- ENLT $35.99
- Analyst Decision
- KNSA Strong Buy
- ENLT Hold
- Analyst Count
- KNSA 7
- ENLT 4
- Target Price
- KNSA $46.86
- ENLT $28.50
- AVG Volume (30 Days)
- KNSA 454.2K
- ENLT 34.8K
- Earning Date
- KNSA 10-28-2025
- ENLT 11-12-2025
- Dividend Yield
- KNSA N/A
- ENLT N/A
- EPS Growth
- KNSA N/A
- ENLT N/A
- EPS
- KNSA 0.47
- ENLT 0.17
- Revenue
- KNSA $597,973,000.00
- ENLT $428,715,000.00
- Revenue This Year
- KNSA $53.93
- ENLT $355.90
- Revenue Next Year
- KNSA $25.06
- ENLT $42.83
- P/E Ratio
- KNSA $84.46
- ENLT $208.30
- Revenue Growth
- KNSA 55.68
- ENLT 39.54
- 52 Week Low
- KNSA $17.82
- ENLT $14.01
- 52 Week High
- KNSA $42.05
- ENLT $36.65
- Technical
- Relative Strength Index (RSI)
- KNSA 50.20
- ENLT 68.49
- Support Level
- KNSA $35.53
- ENLT $34.96
- Resistance Level
- KNSA $41.28
- ENLT $36.65
- Average True Range (ATR)
- KNSA 1.50
- ENLT 0.75
- MACD
- KNSA -0.14
- ENLT 0.01
- Stochastic Oscillator
- KNSA 43.13
- ENLT 83.08
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.